Study finds eczema-linked protein helps ovarian cancer survive ...
6 days ago · This new study suggests dupilumab or similar drugs could be repurposed to enhance immunotherapy for ovarian cancer. Ovarian cancer is one of the most deadly cancers; 50% of patients die within ...
No More “Wait and See”: Two Clinical Trials Target the Origins of ...
Sep 26, 2024 · Now, Break Through Cancer, a Boston-based cancer research foundation, announces two groundbreaking collaborative studies to evaluate methods to detect, monitor and target MRD in ovarian cancer, one of the leading causes of cancer deaths among women.
Discovery reveals how ovarian cancer disables immune cells
Oct 24, 2024 · Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack – blocking the energy supply T cells depend on. The work, published Oct. 23 in Nature, points toward a promising new immunotherapy approach for ovarian cancer, which is notoriously aggressive and hard to treat.
FDA Approval Sought for Avutometinib Plus Defactinib in …
4 days ago · A rolling NDA seeking the approval of avutometinib plus defactinib in recurrent KRAS-mutant low-grade serous ovarian cancer has been submitted to the FDA. News OncClub All Oncology News Pipeline ...
Mirvetuximab Soravtansine-Gynx Approved for Ovarian Cancer
Apr 24, 2024 · Platinum-resistant ovarian cancer has proven difficult to treat, but with the Food and Drug Administration’s recent full approval of mirvetuximab soravtansine-gynx (Elahere), some people in this situation now have a new treatment option.
Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer
22 hours ago · The median PFS was 6.9 months (95% CI, 4.2-9.6). “SHR-A1921 demonstrated promising efficacy in heavily pretreated patients with platinum-resistant ovarian cancer,” Professor Dihong Tang, MD, of the Department IV of Gynecology at Hunan Cancer Hospital in Changsha, China, and colleagues, wrote in the presentation.
Ovarian cancer: New treatments and research
May 1, 2024 · If you've been diagnosed with ovarian cancer, he wants you to know there is hope. Here's why: New targeted therapies are improving survival. Surgery and chemotherapy are no longer the only options for ovarian cancer treatment. Targeted therapies use drugs to target and attack cancer cells.
Antibody drug conjugates make strides in ovarian cancer with …
Feb 12, 2024 · The UCLA Health women’s cancer research team in OBGYN played a pivotal role in a clinical trial that led to the FDA granting accelerated approval of the first antibody drug conjugate for the treatment of platinum-resistant ovarian cancer.
A Game-Changer for Ovarian Cancer | Johns Hopkins Medicine
Jun 6, 2024 · Ovarian cancer is a notoriously difficult group of diseases to diagnose and treat. There is no effective screening method — most people have widely metastatic cancer when they start showing symptoms, and most patients die within five years.
Ovarian Cancer News - ScienceDaily
Aug 13, 2024 · Information about ovarian cancer symptoms and treatments. Explore the latest medical research on ovarian cysts and ovarian cancer including including stages of the disease and new treatment...